researching the key technologies of prevention, screening, diagnosis and treatment of Alzheimer's disease


Qankorey Technology Co.,Ltd, founded in 2014, is a Sino-foreign joint venture focusing on the crucial technological research of Alzheimer Disease, which is a medical thorny problem.

Globally, Qankorey is the first medical device for early screening of dementia using urine. We are a national high-tech enterprise, as well as a governing institution of China Association for Alzheimer's Disease.

R&D Center

Changsha R&D center

The head-quarter and domestic R&D center are in Changsha. The equipment of the R&D center has been invested over 50 millions, covering 2000 squares, and the annual output is planning to reach 2 billion yuan. There are three 10,000 degree clean workshops and one 100,000 degree clean workshops.

Melbourne R&D Center

Melborne R&D center focuses on the translational research in novel diagnostic products and new treatment methods for neurodegenerative diseases and cancer/leukemia.


The team in Melbourne consists of 7 doctors. Ben Gu, phD Supervisor, is the chief scientist of Qankorey. He has worked in senile dementia over 10 years. Besides, he is the founder of innate phgocytosis.


We devote ourselves to be the server of AD field, and our mission is to help aged people to live well and live longer.  

Besides, we are focusing on providing a integrated comprehensive solution for AD and other types of dementia, including the prevention, prediction, intervention and treatment of age-related disorders.

  • WhatsApp/WeChat:+8618874232226
  • Address:Floor 12, Building 15, No. 188, Middle Environmental Protection Road, Yuhua District, Changsha City, Hunan Province

Website Navigation

Scan QR code

Applets 二维码
  • WeChat QR code

    WeChat QR Code

免责声明:本站支持广告法相关规定, 且已竭力规避使用“极限化违禁词",如不慎出现仅代本站范围内对比,不支持以任何"违禁词”为借口举报我司违反《广告法》的变相勒索行为!本站部分素材来源互联网,以传播信息为目的进行转载,如涉及版权请直接与客服联系,我们将及时更正删除,谢谢。